When to Check B12 and Vitamin D Levels
Check vitamin B12 and 25-hydroxyvitamin D levels in patients with specific risk factors or clinical conditions rather than screening the general population—vitamin D testing is indicated for bone fragility, malabsorption, chronic kidney disease, and phosphocalcic disorders, while B12 testing should be performed when evaluating anemia, neurological symptoms, or in patients with malabsorption syndromes.
Vitamin D Testing Indications
Do NOT Screen the General Population
The USPSTF explicitly recommends against population-wide screening for vitamin D deficiency 1. No national primary care organization supports universal screening 1. The Endocrine Society similarly states there is no evidence showing benefits of screening at a population level 1.
Specific Clinical Situations Warranting Vitamin D Testing
Test vitamin D (25-hydroxyvitamin D) in these conditions:
- Bone fragility disorders including low bone mineral density, low-energy fractures, or osteoporosis 2, 3
- Malabsorption syndromes of any etiology 2, 3
- Chronic kidney disease and kidney transplant recipients 3
- Any phosphocalcic pathology or when exploring calcium/phosphorus metabolism (including PTH measurement) 2, 3
- Clinical signs of profound vitamin D deficiency or excess (e.g., diffuse pain, elderly with recurrent falls) 3
- Primary hyperparathyroidism 3
- Granulomatous diseases 3
- Patients receiving treatments causing bone loss or modifying vitamin D metabolism (e.g., anticonvulsants) 3
Additional High-Risk Groups
Consider testing in patients aged >65 years, pregnant women, those with recurrent falls, secondary hyperparathyroidism, or cancer 4. The ESPEN guideline notes that patients requiring nutritional therapy are frequently depleted in vitamin D due to low intake and lack of UV light 5.
Target Levels
When testing is indicated, aim for 25-hydroxyvitamin D levels of 20-60 ng/mL (50-100 nmol/L) for most patients 6, 4. Higher targets of >30 ng/mL may benefit specific populations including elderly, pregnant women, and those with osteoporosis or chronic kidney disease 4.
Vitamin B12 Testing Indications
Clinical Scenarios for B12 Testing
Test vitamin B12 in these situations:
- Macrocytic anemia or unexplained anemia 7
- Neurological symptoms including cognitive changes, developmental delay, or peripheral neuropathy 7
- Malabsorption syndromes (celiac disease, inflammatory bowel disease, post-gastric surgery) 7
- Suspected pernicious anemia (the most common non-dietary cause of B12 deficiency) 7
- Elderly patients with bone health concerns, particularly women with osteoporosis 8
- Patients with unexplained fatigue and weakness 9
Important Consideration
There is a significant association between vitamin D deficiency and vitamin B12 deficiency 9. When one deficiency is identified, consider testing for the other, particularly in children and adolescents where the co-occurrence rate is substantial 9.
Common Pitfalls to Avoid
- Don't order routine screening in asymptomatic, low-risk individuals—this wastes resources and may lead to unnecessary treatment
- Don't measure vitamin D metabolites other than 25-hydroxyvitamin D for assessing vitamin D status 5
- Don't forget seasonal variation in vitamin D levels (lowest after winter) when interpreting results 5
- Recognize that vitamin B12 deficiency is particularly common in adolescents (>12 years) and should be considered in this age group 9
- Use LC-MS/MS methodology when available for vitamin D testing as it is the gold standard 5
Treatment Without Testing
For many patients, empiric supplementation without testing is appropriate and cost-effective 3. The recommended daily allowance is 600-800 IU for adults (vitamin D) 1, 5, and treatment is inexpensive with a large safety margin. Consider empiric supplementation rather than testing in low-risk individuals who would benefit from supplementation regardless of baseline levels.